title: Prophylactic Octreotide for Pancreatectomy: Benefit or Harm? Correspondence re McMillan et al, 2016;264: 344.
authors.affiliation: Department of Surgery, St. Agnes Hospital, Baltimore, MD Department of Public Health Analysis, School of Community Health and Policy, Morgan State University, Baltimore, MD Department of Surgery, St. Agnes Hospital, Baltimore, MD Department of Surgery, St. Agnes Hospital, Baltimore, MD Department of Surgery, St. Agnes Hospital, 900 Caton Avenue, Baltimore, MD.
authors.forename: Xihua
authors.initials: X
authors.lastname: Yang
authors.forename: Farin
authors.initials: F
authors.lastname: Kamangar
authors.forename: Naeem
authors.initials: N
authors.lastname: Goussous
authors.forename: Shirali T
authors.initials: ST
authors.lastname: Patel
authors.forename: Steven C
authors.initials: SC
authors.lastname: Cunningham
mesh_terms: D005765:Gastrointestinal Agents; D006801:Humans; D015282:Octreotide; D010180:Pancreatectomy; D010185:Pancreatic Fistula; D016577:Pancreaticoduodenectomy
chemical_list: D005765:Gastrointestinal Agents; D015282:Octreotide